KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationInvestment in Debt & EquityLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Inovio Pharmaceuticals (INO) Other Gross PP&E Adjustments (2016 - 2025)

Inovio Pharmaceuticals' Other Gross PP&E Adjustments history spans 15 years, with the latest figure at -$7.0 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments rose 17.89% year-over-year to -$7.0 million; the TTM value through Sep 2025 reached -$7.0 million, up 17.89%, while the annual FY2024 figure was $8.9 million, 29.2% down from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was -$7.0 million at Inovio Pharmaceuticals, up from -$7.4 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $21.2 million in Q4 2021 and bottomed at -$12.8 million in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is -$9.1 million (2023), against an average of -$4.7 million.
  • The largest annual shift saw Other Gross PP&E Adjustments soared 87.12% in 2021 before it fell 29.2% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $21.2 million in 2021, then dropped by 28.78% to $15.1 million in 2022, then dropped by 16.4% to $12.6 million in 2023, then fell by 29.2% to $8.9 million in 2024, then crashed by 177.74% to -$7.0 million in 2025.
  • Per Business Quant, the three most recent readings for INO's Other Gross PP&E Adjustments are -$7.0 million (Q3 2025), -$7.4 million (Q2 2025), and -$7.7 million (Q1 2025).